Clinical Trial

GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of the Alzheimer's Prevention Registry GeneMatch program is to identify a large group of people interested in participating in research studies or clinical trials based in part on their genetic background. This genetic information will be used to match interested individuals to studies, providing a recruitment resource to the Alzheimer's scientific community. Interested individuals should visit www.endALZnow.org/GeneMatch to join the GeneMatch program.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2015-09-29; most recent amendment 2025-12-08.
Status change: Recruiting → Enrolling by Invitation 2025-03-19
Status change: Active, Not Recruiting → Recruiting 2021-06-03
Status change: Recruiting → Active, Not Recruiting 2019-08-27
Status change: Not Yet Recruiting → Recruiting 2015-12-09
Trial Details
NCT Number NCT02564692
Lead Sponsor Banner Health
Conditions Alzheimer Disease
Enrollment 500,000 participants
Start Date 2015-11
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-09